Revelation Biosciences, Inc. (NASDAQ:REVB) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock (or common stock equivalents) and warrants Closed: US$4M raised · US$1.1 a share · Warrants at US$1.1 for 60 months · Roth Capital Partners Dealers: Roth Capital Partners (lead) Use of proceeds: Product candidate development incl. Phase 1b study, clinical drug supply, preclinical work, other products, working capital | May 29, 2025 |